A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
Clinical trial NCT03158025 · COMPLETED
Trial details
- NCT number
- NCT03158025
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2018-07-04
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.